Concepedia

Publication | Open Access

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

DOIFull Paper Access

247

Citations

18

References

2014

Year

Bernard Zinman, Silvio E. Inzucchi, John M. Lachin, Christoph Wanner, Roberto Ferrari, David Fitchett, Erich Bluhmki, Stefan Hantel, Joan Kempthorne‐Rawson, Jennifer Newman,
Cardiovascular Diabetology

References

YearCitations

Page 1